EPAS1 and neoplasm: Knockout of HIF-2α in Foxp3-specific cells resulted in the inability to suppress colitis induced by effector T-cells and a resistance to tumor growth, indicating the potential to target HIF-2α in the TME to control immune tolerance [197].